Envestnet Asset Management Inc Bio Line Rx Ltd. Transaction History
Envestnet Asset Management Inc
- $281 Billion
- Q2 2024
A detailed history of Envestnet Asset Management Inc transactions in Bio Line Rx Ltd. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 213,833 shares of BLRX stock, worth $89,809. This represents 0.0% of its overall portfolio holdings.
Number of Shares
213,833
Previous 54,405
293.04%
Holding current value
$89,809
Previous $60,000
101.67%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding BLRX
# of Institutions
38Shares Held
4.34MCall Options Held
49.9KPut Options Held
122K-
Alyeska Investment Group, L.P. Chicago, IL1.95MShares$820,4130.01% of portfolio
-
Cvi Holdings, LLC Wilmington, DE816KShares$342,5864.05% of portfolio
-
Values First Advisors, Inc.198KShares$82,9560.06% of portfolio
-
Atria Investments LLC Charlotte, NC134KShares$56,2690.0% of portfolio
-
Pvg Asset Management Corp Golden, CO124KShares$51,9030.3% of portfolio
About BioLineRx Ltd.
- Ticker BLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,524,500
- Market Cap $25.8M
- Description
- BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials ...